Imbruvica (ibrutinib) - AbbVie, J&J
Venclexta (venetoclax) - Roche, AbbVie
Zydelig (idelalisib) - Gilead
eprenetapopt (APR-246) - Aprea
https://www.iwcll2025.org/fsPopup.asp?efp=UkpWR0RaQ0YyNDU0NA&PosterID=746368&rnd=0.7549083&mode=posterInfo
 
Irena Velkova, PhD; Martina Pasino, PhD Student; Andrea Speciale, PhD; Silvia Ravera, PhD; Giovanna Cutrona, PhD; Rosanna Massara, BSc; Nadia Bertola, Phd; Maurizio Viale, PhD; Andrea Nicola Mazzarello, PhD; Franco Fais, PhD; Fabrizio Loiacono, PhD; Serena Matis, PhD; Giulia Elda Valenti, PhD; Nicola Traverso, PhD; Cinzia Maria Domenicotti, PhD; Barbara Marengo, PhD; Bruno Tasso, PhD; Adalberto Ibatici, MD; Angelucci Emanuele, MD, PhD; Tiziana Vaisitti, PhD; Paola Monti, PhD; Paola Menichini, PhD
 
Aug 8, 2025
 
Prev Next